Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | SCN1A | P35498 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.41 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.41 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amylocaine SCHEMBL81360 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP1A2CYP2C19TDP1TSHR | |
| Amylocaine SCHEMBL25684 | 0.98 | CYP2D6 (0.97) | CYP2D6CYP1A2CYP2C19TDP1TSHR | |
| Amylocaine SCHEMBL25686 | 0.98 | CYP2D6 (0.97) | CYP2D6CYP1A2CYP2C19TDP1TSHR | |
| Amylocaine SCHEMBL1648490 | 0.97 | CYP2D6 (0.94) | CYP2D6CYP1A2CYP2C19TDP1TSHR | |
| SCHEMBL13514895 | 0.87 | CYP2D6 (0.76) | CYP2D6CYP1A2CYP2C19TDP1TSHR | |
| SCHEMBL1783308 | 0.83 | CYP2D6 (0.71) | CYP2D6CYP1A2CYP2C19TDP1TSHR | |
| SCHEMBL29351583 | 0.83 | CYP2D6 (0.70) | CYP2D6CYP1A2CYP2C19TDP1TSHR | |
| SCHEMBL27692599 | 0.82 | CYP2D6 (0.69) | CYP2D6CYP1A2CYP2C19TDP1TSHR | |
| SCHEMBL28684600 | 0.82 | CYP2D6 (0.69) | CYP2D6CYP1A2CYP2C19TDP1TSHR | |
| SCHEMBL4576579 | 0.79 | CYP2D6 (0.66) | CYP2D6CYP1A2CYP2C19TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1988 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144801-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-05-28 | — | — | US | claimed |
| US-20260115156-A1 | INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT | UNIV KOREA RES & BUS FOUND (KR) | 2026-04-30 | — | — | US | claimed |
| EP-4436552-B1 | GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC | OREXA B V (NL) | 2026-02-04 | — | — | EP | claimed |
| WO-2025235864-A1 | COATED NEEDLE ADMINISTRATION SYSTEMS | EVOLUS, INC. (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250332183-A1 | COMPOSITIONS AND METHODS FOR THE STIMULATION OF INTERMEDIATE MACROPHAGES AND TREATMENTS THEREWITH | AYUVIS RESEARCH, INC. | 2025-10-30 | — | — | US | claimed |
| US-20250319025-A9 | COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-10-16 | — | — | US | claimed |
| EP-4578441-A1 | TREATMENT OF LOCALIZED PAIN | PlantTec Medical GmbH (DE) | 2025-07-02 | — | — | EP | claimed |
| US-20250205278-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | ABBOTT NICHOLAS L (US) | 2025-06-26 | — | — | US | claimed |
| WO-2025128639-A1 | HYDROGELS COMPRISING PROTEIN-STABILIZED NANOPARTICLES FOR EXTENDED RELEASE | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-06-19 | — | — | WO | claimed |
| US-12329856-B2 | Crosslinked hyaluronic acid composition with local anesthetics | BIOPOLIMERI S.R.L. (IT) | 2025-06-17 | — | — | US | claimed |
| EP-0999839-B1 | COMPOSITIONS, KITS, AND METHODS FOR INHIBITING CEREBRAL NEUROVASCULAR DISORDERS AND MUSCULAR HEADACHES | LEVIN BRUCE H (US) | 2004-06-23 | — | — | EP | claimed |
| US-20030027833-A1 | Compositions and delivery systems for administration of a local anesthetic agent | CORIUM INTERNATIONAL, INC. | 2003-02-06 | — | — | US | claimed |
| WO-2002089849-A1 | COMPOSITIONS AND DELIVERY SYSTEMS FOR ADMINISTRATION OF A LOCAL ANESTHETIC AGENT | CORIUM INTERNATIONAL (US) | 2002-11-14 | — | — | WO | claimed |
| US-6432986-B2 | INTRANOSALLY ADMINISTERING OF ANESTHETICS | BHL PATENT HOLDINGS LLC | 2002-08-13 | — | — | US | claimed |
| US-20010055607-A1 | COMPOSITIONS, KITS, AND METHODS FOR INHIBITING CEREBRAL NEUROVASCULAR DISORDERS AND MUSCULAR HEADACHES | BHL PATENT HOLDINGS LLC | 2001-12-27 | — | — | US | claimed |
| US-6297290-B2 | INTENDED TO ANESTHETIZE THE SKIN OR THE MUCOUS MEMBRANES OR TO TREAT PRURITUS. | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOQUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 2001-10-02 | — | — | US | claimed |
| WO-2001043733-A2 | COMPOSITIONS, KITS, APPARATUS, AND METHODS FOR INHIBITING CEPHALIC INFLAMMATION | LEVIN BRUCE H (US) | 2001-06-21 | — | — | WO | claimed |
| US-20010004644-A1 | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation | LEVIN BRUCE H (US) | 2001-06-21 | — | — | US | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010055607-A1 | COMPOSITIONS, KITS, AND METHODS FOR INHIBITING CEREBRAL NEUROVASCULAR DISORDERS AND MUSCULAR HEADACHES | TNNC1, KIT, PDE3A | CYP2D6 2876/4885CYP1A2 2135/4885CYP2C19 906/4885 |
| US-12329856-B2 | Crosslinked hyaluronic acid composition with local anesthetics | CD44, HCAR3, HCAR2 | CYP2D6 1977/4885CYP1A2 1332/4885CYP2C19 434/4885 |
| US-20010004644-A1 | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation | CXCR5, CCL5, C5AR2 | CYP2D6 2490/4885CYP1A2 1652/4885CYP2C19 970/4885 |
| US-20260115156-A1 | INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT | CES2, DAGLA, ACHE | CYP2D6 71/4885CYP1A2 1231/4885CYP2C19 272/4885 |
| US-20250332183-A1 | COMPOSITIONS AND METHODS FOR THE STIMULATION OF INTERMEDIATE MACROPHAGES AND TREATMENTS THEREWITH | CD14, MYADM, MYD88 | CYP2D6 3653/4885CYP1A2 2512/4885CYP2C19 3644/4885 |
| US-20260144801-A1 | COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS | CPT1B, HPGD, PTGES | CYP2D6 756/4885CYP1A2 360/4885CYP2C19 571/4885 |
| US-20250319025-A9 | COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF | PHOSPHO1, SGMS1, LIPA | CYP2D6 2874/4885CYP1A2 2988/4885CYP2C19 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.